Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Celldex Therapeutics, Inc. CLDX

Set alert

Price alert · CLDX

All alert types
29.04 USD 0.00 0.00%

At close

29.11 +0.07 +0.24%

Pre-market · Nov 3, 8:45 AM ET

Bid
29.04 × 1
Ask
29.05 × 1
28.61 Day range 30.15
22.10 52-week range 45.14
YTD
+6.92%
1 year
+8.64%
Open
30.10
Prev close
29.04
Mkt cap
2.28B
Vol
956.13K
Avg vol
1.34M
EPS
-4.35
P/E
0.00
Div yield
0.00%
More statistics
Low
28.61
High
30.15
Forward P/E
-6.83
Beta
1.03
Short ratio
4.27
Inst. own
109.99%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
34.06
200-d avg
32.65
1y target
63.07

1M chart

Chart tools
Interval
1m5m15m30m

Signals (10)
NameDateAgo
SMA: BearishNov 2, 202623 hours ago
SMA: BullishOct 23, 20261 week ago
SMA: BearishOct 22, 20261 week ago
SMA: BullishOct 19, 20262 weeks ago
MACD: Buy SignalOct 19, 20262 weeks ago
RSI: OversoldOct 16, 20262 weeks ago
RSI: OversoldOct 12, 20263 weeks ago
RSI: OversoldOct 8, 20263 weeks ago
SMA: BearishOct 6, 20264 weeks ago
SMA: BullishOct 5, 20264 weeks ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 63.07 +117.2% upside
Target (low)
28.00
Target (mean)
63.07
Target (high)
100.00
Ratings (0m) 15 14 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy12
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 15
  • 1 month ago 15
  • 2 months ago 16

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CLDX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.01-1.07 – -0.94-1.01-0.1%883.22K0.0%10
Next quarter-1.01-1.12 – -0.87-1.22+17.2%1.22M+911.2%10
Current year-4.12-4.33 – -3.71-3.90-5.7%1.85M+19.7%10
Next year-4.25-5.00 – -3.26-4.12-3.1%8.76M+373.5%10

Upgrades and downgrades

The latest rating changes

CLDX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 2, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 23, 2026Leerink PartnersMaintainedOutperformOutperform
Sep 23, 2026Morgan StanleyMaintainedOverweightOverweight
Sep 22, 2026HC Wainwright & Co.MaintainedBuyBuy
Sep 22, 2026Cantor FitzgeraldMaintainedOverweightOverweight
Sep 10, 2026Morgan StanleyMaintainedOverweightOverweight
Aug 7, 2026Morgan StanleyMaintainedOverweightOverweight
Aug 7, 2026BarclaysMaintainedOverweightOverweight
Jul 29, 2026Wells FargoMaintainedOverweightOverweight
Jul 22, 2026Wells FargoMaintainedOverweightOverweight
Jul 22, 2026Morgan StanleyMaintainedOverweightOverweight
Jul 22, 2026Cantor FitzgeraldMaintainedOverweightOverweight
Jul 22, 2026Canaccord GenuityMaintainedBuyBuy
Jul 20, 2026GuggenheimMaintainedBuyBuy
Jun 15, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jun 10, 2026UBSMaintainedBuyBuy
May 13, 2026Wells FargoMaintainedOverweightOverweight
May 8, 2026BarclaysMaintainedOverweightOverweight
Apr 20, 2026BarclaysUpgradeUnderweightOverweight
Mar 2, 2026Goldman SachsMaintainedNeutralNeutral
Feb 26, 2026StifelReiteratedBuyBuy
Dec 17, 2025BarclaysMaintainedUnderweightUnderweight
Nov 11, 2025BarclaysMaintainedUnderweightUnderweight
Oct 21, 2025MizuhoInitiated—Outperform
Oct 13, 2025BarclaysInitiated—Underweight
Sep 17, 2025Canaccord GenuityMaintainedBuyBuy
Aug 20, 2025Wells FargoMaintainedOverweightOverweight
Aug 20, 2025CitigroupMaintainedBuyBuy
Aug 20, 2025Canaccord GenuityMaintainedBuyBuy
Aug 20, 2025HC Wainwright & Co.MaintainedBuyBuy